Panagiotis Doukas: Plasma Desmosine as a Biomarker of Increased Proteolytic Activity in the Aortic Wall
Panagiotis Doukas, Resident Physician at Uniklinik RWTH Aachen, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I am happy to announce the results of our latest research collaboration with the University of Dundee, Cardiovascular Research Institute Maastricht (CARIM), the Institute of Immunology at Uniklinik RWTH Aachen, and the Institute for Transfusion Medicine and Cell Therapeutics at Uniklinik RWTH Aachen.
In this case–control study on thoracoabdominal aortic aneurysm physiology, we demonstrate that plasma desmosine can reliably discriminate TAAA patients from healthy controls. Importantly, we also show for the first time a direct association between circulating plasma desmosine levels and matrix metalloproteinase expression within the aortic wall.
These findings suggest plasma desmosine as a biomarker of increased proteolytic activity in the aortic wall, independent of aortic diameter and highlight its potential relevance for improved risk stratification beyond size criteria alone.
Grateful to all collaborators for this productive and truly interdisciplinary effort.”
Title: Plasma Desmosine Is Elevated in Thoracoabdominal Aortic Aneurysms and Is Associated with Intramural Proteolytic Activity
Authors: Panagiotis Doukas, Cathryn Bassett, Bernhard Hruschka, Elena Kuzmanova, Inga Wessels, Hannes J. Klump, Leon J. Schurgers, Michael J. Jacobs, Christian Uhl, Alexander Gombert, Jeffrey T. J. Huang
Read the Full Article on International Journal of Molecular Sciences
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Mar 18, 2026, 16:34Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline
-
Mar 18, 2026, 16:19Cedric Hermans: Unleashing the Potential of Physical Activity in Hemophilia A Patients
-
Mar 18, 2026, 16:17Asif Mushtaq: Managing Cardiac Surgery with Cardiopulmonary Bypass in Hemophilia
-
Mar 18, 2026, 16:15Amir Kraitzer: Engineering Hemocompatible Surfaces to Overcome Thrombosis in Medical Devices
-
Mar 18, 2026, 16:11Hemant Sharma: Advancing Neonatal Care with New Strategies to Prevent IVH
-
Mar 18, 2026, 16:09Yves Bikorimana: How a Simple Temperature Change Can Trigger Antibody-Mediated Destruction of RBCs
-
Mar 18, 2026, 16:07Scott Isaacs: Optimizing Brain Vitality and Slowing Neurodegeneration Through Daily Habits